• Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
JOURNAL POLICIES
FOR CONTRIBUTORS

Page Path

5
results for

"Systemic lupus erythematosus"

Filter

Article category

Keywords

Publication year

Authors

"Systemic lupus erythematosus"

Case Reports

[English]
Late-onset Systemic Lupus Erythematosus with Protein-losing Enteropathy, Vitiligo, and Diffuse Alveolar Hemorrhage
Masashi Ohe, Risshi Kudoh, Masahide Seki, Motohiro Endo, Mirei Shiki
Ewha Med J 2015;38(3):121-125.   Published online October 31, 2015
DOI: https://doi.org/10.12771/emj.2015.38.3.121

A 60-year-old man who had been diagnosed with protein-losing enteropathy (PLE) and vitiligo at age 51 years was admitted with dyspnea, hemoptysis, and lower-limb edema. On the basis of computed tomography findings, the cause of respiratory symptoms was thought to be diffuse alveolar hemorrhage (DAH). The final diagnosis of late-onset systemic lupus erythematosus (SLE) was established on the basis of renal biopsy examinations that revealed evidence of active SLE with lupus nephritis (World Health Organization, class V) and positive results for antinuclear antibody. DAH, as well as PLE and vitiligo were attributed to SLE. The patient was successfully treated with methylprednisolone and then prednisolone in combination with cyclosporin A. Because late-onset SLE is rare and patients tend to show atypical symptoms, close attention should be paid to the preceding symptoms.

Citations

Citations to this article as recorded by  
  • Gastrointestinal system involvement in systemic lupus erythematosus
    Z Li, D Xu, Z Wang, Y Wang, S Zhang, M Li, X Zeng
    Lupus.2017; 26(11): 1127.     CrossRef
  • 96 View
  • 0 Download
  • 1 Crossref
[English]
Systemic Lupus Erythematosus with Initial Presentation of Ascites
Ji Min Chu, San Ha Kang, Ji Hyun Song, Kyu Hyun Han, Sun Young Shin, Tae Young Yang, Jin Jung Choi, Sung Pyo Hong
Ewha Med J 2014;37(2):121-125.   Published online September 30, 2014
DOI: https://doi.org/10.12771/emj.2014.37.2.121

Systemic lupus erythematosus (SLE) is a chronic inflammatory disease of unknown etiology and is characterized by presence of variable pathogenic auto-antibodies and multiple organ involvement. Serositis is common in SLE, but peritoneal involvement is relatively rare. This is a case report of 28-year-old female who initially presented with abdominal pain and ascites. After ruling out many other possibilities such as liver cirrhosis, neoplasm, and infectious etiologies, we confirmed SLE with clinical features, serologic tests and radiological findings. To conclude, her abdominal pain and ascites were caused by lupus peritonitis. After administration of corticosteroid therapy, her symptoms fairly improved.

  • 71 View
  • 0 Download
[English]
Minimal Change Disease in Systemic Lupus: Another Renal Manifestation of Lupus?
Ki Heon Nam, Yoon Jin Cha, Young Eun Kwon, Yung Ly Kim, Kyoung Sook Park, Seong Yeong An, Beom Jin Lim, Hyeon Joo Jeong, Hyung Jung Oh, Tae-Hyun Yoo, Shin-Wook Kang, Kyu Hun Choi, Seung Hyeok Han
Ewha Med J 2013;36(2):139-143.   Published online September 26, 2013
DOI: https://doi.org/10.12771/emj.2013.36.2.139

Nephrotic syndrome is most commonly observed in membranous lupus nephritis in patients with systemic lupus erythematosus (SLE). However, other forms of idiopathic nephrotic syndrome rarely occur in these patients. Here, we report a case of SLE complicated by minimal change disease (MCD). A 24-year-old woman with SLE visited our hospital for generalized edema and heavy proteinuria. Laboratory tests did not support immunological exacerbation of lupus, while renal biopsy revealed diffusely effaced foot processes without electron-dense deposits that were consistent with MCD. Administration of high-dose corticosteroids and 6 subsequent cycles of monthly intravenous cyclophosphamide resulted in complete remission. Although nephrotic-range proteinuria recurred 1 month after switching to maintenance therapy with mycophenolate mofetil, complete remission was reestablished after a 6-month treatment with corticosteroids and cyclosporine. Physicians should be cautious in assessment and management of such a rare renal manifestation.

Citations

Citations to this article as recorded by  
  • A Unique Cause of Proteinuria in Pregnancy: Class II Lupus Nephritis with Concomitant Minimal Change Disease
    Ryan Kunjal, Rabie Adam-Eldien, Raafat Makary, Francois Jo-Hoy, Charles W. Heilig
    Case Reports in Nephrology and Dialysis.2016; 6(3): 101.     CrossRef
  • 95 View
  • 0 Download
  • 1 Crossref
Original Articles
[English]
Analysis of Circulating B-1 B Lymphocyte Subsets in Patients with Systemic Lupus Erythematosus
Su Jung Baik, Jisoo Lee, You-Hyun Lee
Ihwa Ŭidae chi 2006;29(2):81-88.   Published online September 30, 2006
DOI: https://doi.org/10.12771/emj.2006.29.2.81
Objectives

To define the abnormalities in homeostasis of B-1 B lymphocytes compartments in human SLE.

Methods

Perpheral blood was obtained from 7 patients with untreated active SLE patients and same patients at the time of incative disease after immunosuppressive therapy. The frequencies of CD5+CD45RAint B-1a B lymphocyte, and CD5+CD45RAlow B-1b B lymphocyte, CD5-CD45RAhigh conventional B-2 lymphocyte subsets were analyzed. For the control group, peripheral blood from 7 healthy adults and 7 patients with infectious fever were utilized.

Results

B-1a B lymphocyte subset was found at high frequency in active SLE patients compared to the fever control(33.5±15.0% vs 20.1±5.3%,p=0.01). In contrast, B-2 B lymphocyte subset was found at lower frequency compared to the fever control (65.6±15.1% vs 77.9±5.6%,p=0.04). No difference in frequency of B-1b B lymphocyte subsets was found between active SLE and the control. After immunosuppressive theray, B-1b B lymphocyte subset was markedly decreased with increase in B-2 B lymphocyte subset(p=0.05).

Conclusion

These results indicate that there are abnormalities in B cell conpartments with expansion of B-1a B lymphocyte subset and contraction of B-2 B lymphocyte subset associated with the disease activity in patients wite SLE.

  • 53 View
  • 0 Download
[English]
The Significance of IL-6 in Systemic Rheumatic Diseases: Systemic Lupus Erythematosus and Rheumatoid Arthritis
Jung Soo Lee, Wha Soon Cjung
Ihwa Ŭidae chi 1999;22(2):131-137.   Published online June 30, 1999
DOI: https://doi.org/10.12771/emj.1999.22.2.131

Systemic lupus erythematosus(SLE) and rheumatoid arthritis(RA) are the widely recognized rheumatic diseases of unknown etiology in which extensive immune dysfunction has been reported. Cytokines are considered to be the most important secretions of the immune system that participate in a variety of cellular, inflammatory and pathogenic processes in human disease. Since imbalance of the cytokine network in autoimmune disease may be detrimental for the severity or clinical manifestation of the disease, I determined serum level of IL-6 in patients with SLE, RA, and normal controls.

The results were as follows:

1) The serum levels of IL-6 in patients with SLE(p=0.0032) and RA(p=0.0001) were significantly higher than those of normal controls.

2) The serum levels of ESR, CRP, and complements did not correlated with serum IL-6 levels. Only the levels of anti-dsDNA in patients with SLE showed correlation with that of serum IL-6. And the serial follow-up of serum IL-6 levels in 6 systemic lupus erythematosus patients show no significant correlation.

3) There were no significant correlation between serum IL-6 of RA patients and disease activity markers such as CRP and rheumatoid factors.

This results indicate that serum IL-6 levels of SLE and RA patients were significantly higher than that of normal controls, and needs further study to be used as a marker for disease activity.

  • 53 View
  • 0 Download
TOP